AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, vitamins, supplements, gastrointestinal, dermatology, and hospital. It has a research and development collaboration with Belgium's Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

CEO

ISIN

NZAFTE0001S4

Listings

AFT.NZ

AFP.AU

0 Comments

Share your thoughts

FAQ

What is AFT Pharmaceuticals Limited stock price today?▼

The current price of AFT.NZ is NZ$3.36 NZD — it has increased by +0.3% in the past 24 hours. Watch AFT Pharmaceuticals Limited stock price performance more closely on the chart.

What is AFT Pharmaceuticals Limited stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange AFT Pharmaceuticals Limited stocks are traded under the ticker AFT.NZ.

What is AFT Pharmaceuticals Limited market cap?▼

Today AFT Pharmaceuticals Limited has the market capitalization of 352.35M

What is AFT Pharmaceuticals Limited revenue for the last year?▼

AFT Pharmaceuticals Limited revenue for the last year amounts to 416.04M NZD.

What is AFT Pharmaceuticals Limited net income for the last year?▼

AFT.NZ net income for the last year is 22.8M NZD.

Does AFT Pharmaceuticals Limited pay dividends?▼

Yes, AFT.NZ dividends are paid annual. The last dividend per share was 0.02 NZD. As of today, Dividend Yield (FWD)% is 0.54%.

When did AFT Pharmaceuticals Limited complete a stock split?▼

AFT Pharmaceuticals Limited has not had any recent stock splits.